PharmOncology

The dangers of cross-trial comparisons


Listen Later

Why it's hard to compare adverse events across trials

Capitello-291: https://www.nejm.org/doi/full/10.1056/NEJMoa2214131


Capitello-281:

https://pubmed.ncbi.nlm.nih.gov/41120017/

...more
View all episodesView all episodes
Download on the App Store

PharmOncologyBy Ming-Hei Tai